Please find attached the copies of certificates received from Kfin Technologies Limited under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter ended ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has submitted to BSE the certificates received from its Registrar and Share Transfer Agent, KFin Technologies Limited, under SEBI Regulation 74(5) for the quarter ended December 31, 2025. Two separate certificates were filed — one from NSDL and one from CDSL — both confirming that the details of securities dematerialized and rematerialized during the quarter have been furnished to the stock exchanges where the company's shares are listed. This is a routine, periodic compliance submission mandated by SEBI's Depository and Participants Regulations, 2018. No specific share movement numbers, corporate action, or material business update is disclosed in this filing.
This is a standard regulatory compliance certificate with no material impact on shareholders, fundamentals, or stock price. It simply confirms the company's depositary reconciliation obligations have been met for the quarter.